UNIGE document Scientific Article
previous document  unige:31685  next document
add to browser collection
Title

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011

Authors
Jordan, M R
Bennett, D E
Wainberg, M A
Havlir, D
Hammer, S
Yang, C
Morris, L
Peeters, M
show hidden authors show all authors [1 - 25]
Published in Clinical infectious diseases. 2012, vol. 54 Suppl 4, p. S245-9
Abstract The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.
Keywords Anti-Retroviral Agents/pharmacologyDeveloping CountriesDrug Resistance, ViralHIV Infections/drug therapyHealth PolicyHealth SurveysHumansWorld HealthWorld Health Organization
Identifiers
PMID: 22544182
Full text
Article (Published version) (226 Kb) - public document Free access
Structures
Research group VIH/SIDA (930)
Citation
(ISO format)
JORDAN, M R et al. Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. In: Clinical infectious diseases, 2012, vol. 54 Suppl 4, p. S245-9. doi: 10.1093/cid/cis206 https://archive-ouverte.unige.ch/unige:31685

501 hits

492 downloads

Update

Deposited on : 2013-12-04

Export document
Format :
Citation style :